<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - OFLOXACIN</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>OFLOXACIN</h1>

        <p><a href="../drugClass/PHP34649.html">QUINOLONES</a></p>

      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#renalImpairment" data-toggle="tab">Renal impairment</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Local treatment of infections</span>,
            </h4>
            <p class="specificity"><span class="route">To the eye</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply every 2&#8211;4 hours for the first 2 days, then reduced to 4 times a day for maximum 10 days treatment.</li>
              <li class="dose child"><strong>For children 1&#8211;17 years</strong><br/>
                Apply every 2&#8211;4 hours for the first 2 days, then reduced to 4 times a day for maximum 10 days treatment.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Urinary-tract infections</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                200&#8211;400 mg daily, preferably taken in the morning; increased if necessary to 400 mg twice daily, in upper urinary tract infections.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Complicated urinary-tract infection</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                200 mg dailyIncreased to 400 mg twice daily, for severe or complicated infections, to be given over at least 30 minutes for each 200 mg.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Acute or chronic prostatitis</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                200 mg twice daily for 28 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Lower respiratory-tract infections</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                400 mg daily, dose preferably taken in the morning, then increased if necessary to 400 mg twice daily.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                200 mg twice daily. increased to 400 mg twice daily, for severe or complicated infections. To be given over at least 30 minutes for each 200 mg.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Skin and soft-tissue infections</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                400 mg twice daily.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                400 mg twice daily, to be given over at least 30 minutes for each 200 mg.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Uncomplicated gonorrhoea</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                400 mg once daily as a single dose.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Uncomplicated genital chlamydial infection</span>,
                <span class="indication">Non-gonococcal urethritis</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                400 mg daily for 7 days, dose may be taken as a single daily dose or in divided doses.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Pelvic inflammatory disease</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                400 mg twice daily for 14 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Septicaemia</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                200 mg twice daily. increased to 400 mg twice daily, for severe or complicated infections. To be given over at least 30 minutes for each 200 mg.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
      </section>



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <h3 class="specificity">When used by <ph outputclass="route">eye</ph></h3>
              <p>Manufacturer advises use only if benefit outweighs risk (systemic quinolones have caused arthropathy in <i>animal</i> studies).</p>
            </section>
      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use or <ph outputclass="route">oral</ph> use in adults</h3>
              <p>Use with caution; elimination may be reduced in severe impairment.</p>
            </section>
      </section>

      <section class="tab-pane" id="renalImpairment">
        <h2>Advice regarding renal impairment</h2>

            <section class="doseAdjustments">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use or <ph outputclass="route">oral</ph> use in adults</h3>
              <p>Usual initial dose, then use half normal dose if eGFR 20&#8211;50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>; 100&#8239;mg every 24 hours if eGFR less than 20&#8239;mL/ minute/1.73&#8239;m<sup>2</sup>
            </p>
            </section>
        
      </section>


      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

        
          <h3>Specific side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> eye irritation in adults, ocular discomfort, cough in adults, eye irritation in adults, nasopharyngitis in adults, cough in adults, eye irritation in adults, nasopharyngitis in adults,
              </p>
              <p>
                <strong>rare:</strong> abnormal dreams in adults, arrhythmias in adults, bronchospasm in adults, dyspnoea in adults, hot flushes in adults, hyperhidrosis in adults, abnormal dreams in adults, arrhythmias in adults, bronchospasm in adults, dyspnoea in adults, hot flushes in adults, hyperhidrosis in adults,
              </p>
              <p>
                <strong>veryRare:</strong> extrapyramidal symptoms in adults, neuropathy in adults, tinnitus in adults, extrapyramidal symptoms in adults, neuropathy in adults, tinnitus in adults,
              </p>
              <p>
                <strong>notKnown:</strong> dry eyes, facial oedema, increased lacrimation, keratitis, ocular hyperaemia, ocular oedema, photophobia, visual disturbances, myopathy in adults, changes in blood sugar in adults, hypotension in adults, local reactions in adults, pneumonitis in adults, rhabdomyolysis in adults, thrombophlebitis in adults, changes in blood sugar in adults, myopathy in adults, pneumonitis in adults, rhabdomyolysis in adults,
              </p>
        
        
      </section>


      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

      </section>



      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
              <strong>When used by eye:</strong>
            corneal ulcer (risk of corneal perforation)
          </li>
          <li>
              <strong>When used by eye:</strong>
            epithelial defect (risk of corneal perforation)
          </li>
          <li>
              <strong>With intravenous use:</strong>
            acute myocardial infarction (risk factor for QT interval prolongation) in adults
          </li>
          <li>
              <strong>With intravenous use:</strong>
            bradycardia (risk factor for QT interval prolongation) in adults
          </li>
          <li>
              <strong>With intravenous use:</strong>
            congenital long QT syndrome (risk factor for QT interval prolongation) in adults
          </li>
          <li>
              <strong>With intravenous use:</strong>
            electrolyte disturbances (risk factor for QT interval prolongation) in adults
          </li>
          <li>
              <strong>With intravenous use:</strong>
            heart failure with reduced left ventricular ejection fraction (risk factor for QT interval prolongation) in adults
          </li>
          <li>
              <strong>With intravenous use:</strong>
            history of psychiatric illness in adults
          </li>
          <li>
              <strong>With intravenous use:</strong>
            history of symptomatic arrhythmias (risk factor for QT interval prolongation) in adults
          </li>
          <li>
              <strong>With oral use:</strong>
            acute myocardial infarction (risk factor for QT interval prolongation) in adults
          </li>
          <li>
              <strong>With oral use:</strong>
            bradycardia (risk factor for QT interval prolongation) in adults
          </li>
          <li>
              <strong>With oral use:</strong>
            congenital long QT syndrome (risk factor for QT interval prolongation) in adults
          </li>
          <li>
              <strong>With oral use:</strong>
            electrolyte disturbances (risk factor for QT interval prolongation) in adults
          </li>
          <li>
              <strong>With oral use:</strong>
            heart failure with reduced left ventricular ejection fraction (risk factor for QT interval prolongation) in adults
          </li>
          <li>
              <strong>With oral use:</strong>
            history of psychiatric illness in adults
          </li>
          <li>
              <strong>With oral use:</strong>
            history of symptomatic arrhythmias (risk factor for QT interval prolongation) in adults
          </li>
        </ul>
      </section>













      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of OFLOXACIN</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        
          <strong>Forms available from special-order manufacturers include: </strong>
            oral suspension,
            oral solution,

            <div id="PHP74657"><a href="../medicinalForm/PHP74657.html" data-target="#PHP74657" data-action="load">Tablet</a></div>
            <div id="PHP74675"><a href="../medicinalForm/PHP74675.html" data-target="#PHP74675" data-action="load">Solution for infusion</a></div>
            <div id="PHP74666"><a href="../medicinalForm/PHP74666.html" data-target="#PHP74666" data-action="load">Eye drops</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
